Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
47,633.84
41,318.29
38,129.98
38,638.06
31,493.98
28,699.70
31,295.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
47,633.84
41,318.29
38,129.98
38,638.06
31,493.98
28,699.70
31,295.94
Raw Material Cost
31,855.68
28,774.02
27,952.17
28,376.69
20,906.00
19,604.67
22,214.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
133.81
124.62
20.35
52.52
51.09
51.78
70.57
Selling and Distribution Expenses
8,128.19
7,379.40
6,738.99
6,576.45
5,768.16
5,592.24
5,444.30
Other Expenses
116.87
121.13
138.42
140.32
137.08
141.64
145.21
Total Expenditure (Excl Depreciation)
41,286.38
37,489.40
36,095.66
36,408.87
28,096.03
26,665.07
29,181.97
Operating Profit (PBDIT) excl Other Income
6347.5
3828.8999999999996
2034.3000000000002
2229.2
3398
2034.6000000000001
2114
Other Income
37.48
142.53
43.51
611.07
470.23
-107.62
-121.19
Operating Profit (PBDIT)
8,791.14
6,210.05
3,965.90
4,744.24
5,715.77
3,314.59
3,346.97
Interest
133.81
124.62
20.35
52.52
51.09
51.78
70.57
Exceptional Items
-89.40
-46.87
-56.98
-13.85
-101.78
-10.98
0.00
Gross Profit (PBDT)
15,778.16
12,544.27
10,177.81
10,261.36
10,587.98
9,095.03
9,080.98
Depreciation
2,406.19
2,238.63
1,888.07
1,903.98
1,847.59
1,387.58
1,354.19
Profit Before Tax
6,161.74
3,799.93
2,000.50
2,773.89
3,715.32
1,864.25
1,922.21
Tax
1,783.21
1,170.63
563.70
733.19
990.50
228.37
459.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,378.53
2,629.30
1,436.80
2,040.70
2,724.81
1,635.88
1,462.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,378.53
2,629.30
1,436.80
2,040.70
2,724.81
1,635.88
1,462.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,378.53
2,629.30
1,436.80
2,040.70
2,724.81
1,635.88
1,462.91
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
38,003.15
32,735.38
29,977.30
28,348.27
25,591.17
23,244.74
22,550.14
Earnings per share (EPS)
264.18
158.85
86.96
123.75
165.56
99.19
88.28
Diluted Earnings per share
264.18
158.85
86.96
123.75
165.56
99.19
88.28
Operating Profit Margin (Excl OI)
13.33%
9.27%
5.34%
5.77%
10.79%
7.09%
6.75%
Gross Profit Margin
17.99%
14.61%
10.2%
12.11%
17.66%
11.33%
10.47%
PAT Margin
9.19%
6.36%
3.77%
5.28%
8.65%
5.7%
4.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 15.28% vs 8.36% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 66.53% vs 83.00% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 44.27% vs 54.69% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 7.38% vs 513.79% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Soken Chemical & Engineering Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
47,633.84
38,843.00
8,790.84
22.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
47,633.84
38,843.00
8,790.84
22.63%
Raw Material Cost
31,855.68
30,164.00
1,691.68
5.61%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
133.81
124.00
9.81
7.91%
Selling and Distribution Expenses
8,128.19
3,812.00
4,316.19
113.23%
Other Expenses
116.87
147.40
-30.53
-20.71%
Total Expenditure (Excl Depreciation)
41,286.38
35,574.00
5,712.38
16.06%
Operating Profit (PBDIT) excl Other Income
6,347.47
3,269.00
3,078.47
94.17%
Other Income
37.48
191.00
-153.52
-80.38%
Operating Profit (PBDIT)
8,791.14
7,042.00
1,749.14
24.84%
Interest
133.81
124.00
9.81
7.91%
Exceptional Items
-89.40
-33.00
-56.40
-170.91%
Gross Profit (PBDT)
15,778.16
8,679.00
7,099.16
81.80%
Depreciation
2,406.19
3,582.00
-1,175.81
-32.83%
Profit Before Tax
6,161.74
3,299.00
2,862.74
86.78%
Tax
1,783.21
740.00
1,043.21
140.97%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,378.53
2,559.00
1,819.53
71.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,378.53
2,559.00
1,819.53
71.10%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,378.53
2,559.00
1,819.53
71.10%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
38,003.15
46,395.00
-8,391.85
-18.09%
Earnings per share (EPS)
264.18
290.60
-26.42
-9.09%
Diluted Earnings per share
264.18
290.60
-26.42
-9.09%
Operating Profit Margin (Excl OI)
13.33%
8.42%
0.00
4.91%
Gross Profit Margin
17.99%
17.71%
0.00
0.28%
PAT Margin
9.19%
6.59%
0.00
2.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 4,763.38 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 15.28% vs 8.36% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 437.85 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 66.53% vs 83.00% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 875.37 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 44.27% vs 54.69% in Mar 2024
Annual - Interest
Interest 13.38 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 7.38% vs 513.79% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.33%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






